Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2013 2
2014 1
2015 4
2016 5
2017 1
2018 2
2019 9
2020 14
2021 14
2022 20
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Hemiplegic Migraine.
Nandyala A, Shah T, Ailani J. Nandyala A, et al. Among authors: ailani j. Curr Neurol Neurosci Rep. 2023 Jul;23(7):381-387. doi: 10.1007/s11910-023-01277-z. Epub 2023 May 29. Curr Neurol Neurosci Rep. 2023. PMID: 37247170 Review.
Atogepant for the Preventive Treatment of Migraine.
Ailani J, Lipton RB, Goadsby PJ, Guo H, Miceli R, Severt L, Finnegan M, Trugman JM; ADVANCE Study Group. Ailani J, et al. N Engl J Med. 2021 Aug 19;385(8):695-706. doi: 10.1056/NEJMoa2035908. N Engl J Med. 2021. PMID: 34407343 Clinical Trial.
Ubrogepant for the Treatment of Migraine.
Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A. Dodick DW, et al. Among authors: ailani j. N Engl J Med. 2019 Dec 5;381(23):2230-2241. doi: 10.1056/NEJMoa1813049. N Engl J Med. 2019. PMID: 31800988 Clinical Trial.
Cluster Headache: A Review and Update in Treatment.
Suri H, Ailani J. Suri H, et al. Among authors: ailani j. Curr Neurol Neurosci Rep. 2021 May 5;21(7):31. doi: 10.1007/s11910-021-01114-1. Curr Neurol Neurosci Rep. 2021. PMID: 33948734 Review.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Pozo-Rosich P, Ailani J, Ashina M, Goadsby PJ, Lipton RB, Reuter U, Guo H, Schwefel B, Lu K, Boinpally R, Miceli R, De Abreu Ferreira R, McCusker E, Yu SY, Severt L, Finnegan M, Trugman JM. Pozo-Rosich P, et al. Among authors: ailani j. Lancet. 2023 Sep 2;402(10404):775-785. doi: 10.1016/S0140-6736(23)01049-8. Epub 2023 Jul 26. Lancet. 2023. PMID: 37516125 Clinical Trial.
Primary Exercise Headache.
Upadhyaya P, Nandyala A, Ailani J. Upadhyaya P, et al. Among authors: ailani j. Curr Neurol Neurosci Rep. 2020 Apr 15;20(5):9. doi: 10.1007/s11910-020-01028-4. Curr Neurol Neurosci Rep. 2020. PMID: 32296942 Free PMC article. Review.
Acute Migraine Treatment.
Ailani J. Ailani J. Continuum (Minneap Minn). 2021 Jun 1;27(3):597-612. doi: 10.1212/CON.0000000000000956. Continuum (Minneap Minn). 2021. PMID: 34048394 Review.
Atogepant for migraine.
Bedrin K, Ailani J. Bedrin K, et al. Among authors: ailani j. Drugs Today (Barc). 2022 Aug;58(8):399-405. doi: 10.1358/dot.2022.58.8.3408815. Drugs Today (Barc). 2022. PMID: 35983926
81 results